Literature DB >> 2999444

Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion.

M F Frana, J N Behnke, L S Sturman, K V Holmes.   

Abstract

Cell fusion induced by infection with mouse hepatitis virus strain A59 (MHV-A59) varied markedly in extent and time course in four different murine cell lines. When inoculated at a multiplicity of 3 to 5 PFU per cell, the Sac-, L2, and DBT cell lines began to fuse by 7 h, were fused into confluent syncytia by 9 to 12 h, and peeled from the substrate by 10 to 14 h. These virulent virus-cell interactions were in striking contrast to the moderate interaction of MHV-A59 with the 17 Cl 1 cell line, in which only small syncytia were observed 18 h postinoculation, and greater than 50% of the cells remained unfused by 24 h. The yield of infectious virus produced by 17 Cl 1 cells was 10-fold higher than the yields from the other three cell lines. The processing of the nucleocapsid protein, the membrane glycoprotein E1, and the peplomeric glycoprotein E2 were found to differ significantly in the four cell lines. Since the E2 glycoprotein is responsible for virus-induced cell fusion, we attempted to correlate differences in cellular processing of E2 with differences in fusion of infected cells. The predominant intracellular form of E2 in all cell lines was the 180K species. Pulse-chase experiments showed that a small portion of the 17 Cl 1 cell-associated 180K E2 was cleaved by 1 h after synthesis to yield 90K E2, shown in the preceding paper to consist of two different glycoproteins called 90A and 90B (L. S. Sturman, C. S. Ricard, and K. V. Holmes, J. Virol. 56:904-911, 1985). This cleavage occurred shortly before the release of virions from cells, as shown by pulse-chase experiments. After budding at intracellular membranes, virions released into the medium by the four cell lines contained different ratios of 180K to 90K E2. Virions from Sac- cells, which contained 100% 90K E2, fused L2 cells rapidly without requiring virus replication, whereas virions from 17 Cl 1 cells, which had 50% 90K E2, required trypsin activation to induce rapid fusion (Sturman et al., J. Virol. 56:904-911, 1985). The addition of protease inhibitors to the medium markedly delayed L2 cell fusion induced by MHV infection. The extent of coronavirus-induced cell fusion does not depend solely upon the percent cleavage of the E2 glycoprotein by cellular proteases, since extensive fusion was induced by infection of L2 and DBT cells but not 17 Cl 1 cells, although all three cell lines cleaved E2 to the same extent.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999444      PMCID: PMC252664     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Tissue culture cytopathic and plaque assays for mouse hepatitis viruses.

Authors:  J W HARTLEY; W P ROWE
Journal:  Proc Soc Exp Biol Med       Date:  1963-06

2.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  The biology and pathogenesis of coronaviruses.

Authors:  H Wege; S Siddell; V ter Meulen
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

5.  Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage.

Authors:  W Garten; F X Bosch; D Linder; R Rott; H D Klenk
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

6.  Role of protease in mouse hepatitis virus-induced cell fusion. Studies with a cold-sensitive mutant isolated from a persistent infection.

Authors:  H Yoshikura; S Tejima
Journal:  Virology       Date:  1981-09       Impact factor: 3.616

7.  Structural polypeptides of coronavirus IBV.

Authors:  D Cavanagh
Journal:  J Gen Virol       Date:  1981-03       Impact factor: 3.891

8.  Coronavirus glycoprotein E1, a new type of viral glycoprotein.

Authors:  H Niemann; H D Klenk
Journal:  J Mol Biol       Date:  1981-12-25       Impact factor: 5.469

9.  Characterization of coronavirus II. Glycoproteins of the viral envelope: tryptic peptide analysis.

Authors:  L S Sturman; K V Holmes
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

10.  I. Structural proteins: effects of preparative conditions on the migration of protein in polyacrylamide gels.

Authors:  L S Sturman
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

View more
  129 in total

1.  Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion.

Authors:  Z Luo; A M Matthews; S R Weiss
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells.

Authors:  K Narayanan; A Maeda; J Maeda; S Makino
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8.

Authors:  Bruce D Zelus; Jeanne H Schickli; Dianna M Blau; Susan R Weiss; Kathryn V Holmes
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations.

Authors:  Gijs A Versteeg; Paula S van de Nes; Peter J Bredenbeek; Willy J M Spaan
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

5.  Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein.

Authors:  T M Gallagher; S E Parker; M J Buchmeier
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

Review 6.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

7.  Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell.

Authors:  Oliver Wicht; Christine Burkard; Cornelis A M de Haan; Frank J M van Kuppeveld; Peter J M Rottier; Berend Jan Bosch
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59.

Authors:  Erin Hemmila; Claire Turbide; Melanie Olson; Serge Jothy; Kathryn V Holmes; Nicole Beauchemin
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Proteolytic activation of the porcine epidemic diarrhea coronavirus spike fusion protein by trypsin in cell culture.

Authors:  Oliver Wicht; Wentao Li; Lione Willems; Tom J Meuleman; Richard W Wubbolts; Frank J M van Kuppeveld; Peter J M Rottier; Berend Jan Bosch
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.

Authors:  Gregory J Babcock; Diana J Esshaki; William D Thomas; Donna M Ambrosino
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.